Article Details
Retrieved on: 2023-01-03 01:31:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immunovant, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here